What's Mine is Yours:Long-Term Experiences of Good Samaritan Organ Donors by Bramstedt, Katrina A
Bond University
Research Repository
What's Mine is Yours
Bramstedt, Katrina A
Published in:
Journal of Patient Experience
DOI:
10.1177/2374373517718146
Published: 01/03/2018
Document Version:
Publisher's PDF, also known as Version of record
Link to publication in Bond University research repository.
Recommended citation(APA):
Bramstedt, K. A. (2018). What's Mine is Yours: Long-Term Experiences of Good Samaritan Organ Donors.
Journal of Patient Experience, 5(1), 16-20. https://doi.org/10.1177/2374373517718146
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
For more information, or if you believe that this document breaches copyright, please contact the Bond University research repository
coordinator.
Download date: 10 Aug 2019
Research Article
What’s Mine is Yours: Long-Term
Experiences of Good Samaritan
Organ Donors
Katrina A Bramstedt, PhD1
Abstract
This study is a long-term follow-up on the health and quality of life of Good Samaritan living organ donors who donated an
average of 10 years ago. Thirteen donors (kidney, liver, and lung) completed 2 surveys. Data from the RAND 36-Item
Health Survey showed that for all domains, as well as the physical and mental component summary scales, the Good
Samaritan donor outcomes were superior to the general population (P < .0001). Data from the European Living Donor
Satisfaction Survey (EULID) showed that in all 8 theme areas, the donors reported statistically significant positive reactions
as compared to negative reactions. With regard to self-reported health status, there was a strong, positive correlation
between the RAND 36-Item Health Survey and the EULID (n ¼ 13, Pearson correlation coefficient: 0.874). All but 1 donor
reported good, very good, or excellent health status. Although donors overwhelmingly reported positivity about the
donation experience, narrative comments about adverse events and recipient death must keep transplant teams alert to
these critical areas. Good Samaritan organ donors come to the hospital healthy, give a gift to a stranger, and sometimes
leave and linger disabled. Donor teams should be observing, questioning, and responding in an effort to maximize their
welfare. This research is unique because investigation of the long-term health and psychosocial outcomes of Good
Samaritan organ donors is rare. Existing studies that report long-term outcomes of kidney donors do not separately analyze
Good Samaritan donor data from related living donors.
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Introduction
Good Samaritan organ donation, the act of giving a living
organ to a stranger, is a relatively rare but valuable contri-
bution to the organ pool for kidneys as well as liver, lung,
and other tissues (1). The UK’s 2014-2015 Annual Activity
Report (2) indicates 107 such kidney donations but none for
liver or other organs. In 2014, there were 184 kidney and 4
liver Good Samaritan donations in the United States but
none for lung or other organs (3). Good Samaritan donation
has many other names including nonrelated donation, non-
directed donation, anonymous donation, altruistic donation,
and benevolent donation (4,5), but the main concept is that
the donor and recipient are strangers. This study is a long-
term follow-up on the health and quality of life of Good
Samaritans who donated an average of 10 years ago (1). This
research is unique because investigation of the long-term
health and psychosocial outcomes of Good Samaritan
organ donors is rare. Existing studies that report long-term
outcomes of kidney donors do not separately analyze Good
Samaritan donor data from related living donors (6–8), and
thus the resultant pooled data does not allow for exploration
of the experiences of these unique donors.
Methods
Participants
The 22 Good Samaritan living organ donors who partici-
pated in a prior study on altruism and organ donation (1)
were eligible to participate in this follow-up study. These 22
adults resided in United States (n¼ 20), Canada (n¼ 1), and
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Belgium (n ¼ 1) and had been living kidney (n ¼ 16), liver
(n ¼ 5), or lung donors (n ¼ 1).
Survey Distribution
In October 2015, the 22 Good Samaritan living organ donors
indicated above were e-mailed an invitation to participate in
this follow-up study. Those who did not respond were sent a
follow-up e-mail, followed by an invitation via postal mail
(to rule out the original invitation having been blocked by
spam filters). Those who indicated their desire to participate
were sent 2 questionnaires: (1) RAND 36-Item Health
Survey 1.0 (9) and (2) European Living Donor Satisfaction
Survey (EULID) (10). Two participants completed their
surveys telephonically due to computer accessibility issues.
Survey Content
The RAND 36-Item Health Survey (version 1.0) is a vali-
dated tool that explores 8 health domains: physical function-
ing, bodily pain, role limitations due to physical health
problems, role limitations due to personal or emotional
problems, emotional well-being, social functioning,
energy/fatigue (vitality), and general health perceptions.
Additionally, one question is focused on perceived change
in health. The 36 questions are identical to the SF-36 tool
(11), with a slightly altered scoring method. All domains are
scored on a scale from 0 to 100, with 100 representing the
best possible health status. Physical component summary
scores (physical functioning, physically based role limits,
bodily pain, and general health) and mental component sum-
mary (MCS) scores (vitality, social functioning, mental
health, and emotional-based role limits) were also calculated
(12,13). Results were compared with the US normative SF-
36 data (men and women combined, aged 55-64 years) (14)
as this was the most suitable reference range.
The European Living Donor Satisfaction Survey
(EULID) is a validated tool consisting of 54 questions that
explore 3 spheres of the living donation experience: percep-
tion and acceptance of the donation process, quality of life,
and psychological well-being. Four EULID questions
(#45-48) are identical to 4 questions in the RAND 36-Item
Health Survey (version 1.0; #1,32-34). Fifty-two questions
are multiple choice with many using a Likert scale response.
Two questions are open-ended for narrative responses (How
did you experience the recipient’s recovery after the trans-
plantation and how is he now? If there are any comments you
would like to add or feelings to express that you couldn’t
explain through the questionnaire, you can write them down
here.) The survey also contains 6 demographic questions:
age, sex, donation date, relation to recipient, organ donated,
and employment status at the time of donation. There is no
scoring formula for the EULID, rather 47 questions are
grouped into themes and responses categorized according
to positivity, negativity, and neutrality (10).
Statistical Analysis
Statistical significance was analyzed using the following
methods: 2-tailed unpaired t test (GraphPad Software Inc,
La Jolla, California); w2, 2-tailed, 2 degrees of freedom
(Turner online calculator; Southwestern Adventist Univer-
sity, Keene, Texas); Fisher exact test, 2-tailed (BGI Cogni-
tive Genomics, Shenzhen, China); and Pearson correlation
coefficient (Vassarstats, New York). Narrative responses
were coded as follows: positive, negative, and neutral/
mixed.
Study Approval
The study protocol conforms to the ethical guidelines of the
1975 Helsinki Declaration. The study was approved by the
Bond University Human Research Ethics Committee,
approval# 0000015353. All donors gave written consent
to participate.
Results
Thirteen donors (10 kidney, 2 liver, and 1 lung) agreed to
participate in this follow-up study, resulting in a response
rate of 59.1% (13 of 22). Their demographics are reported in
Table 1. The average age of the participants was 58.8 years
(range: 47-70 years; standard deviation [SD]: 7.3) and they
averaged 9.9 years since their donation (range: 5-16 years;
SD: 3.8). Most (69.2%, 9 of 13) had a 4-year university
degree or higher at the time of donation and most (69.2%,
9 of 13) professed a religious affiliation. All are white, non-
Hispanic, 61.5%male. All participants are residents of North
America (12 United States and 1 Canada).
The RAND 36-Item Health Survey results are shown
in Table 2. The US normative SF-36 data associated with
age range 55 to 64 years (males and females combined)
were selected as the closest match with the study popula-
tion age range (47-70 years). For all domains, as well as the
physical and mental component summary scales, the Good
Samaritan donor outcomes were superior to the general
population (P < .0001).
European Living Donor Satisfaction Survey data are
shown in Tables 3 and 4. In all 8 theme areas, the donors
reported statistically significant positive reactions as com-
pared to negative reactions. With regard to the open-ended
narrative responses (Table 4), negative responses were gen-
erally focused on physical complications from donation and
hospital follow-up care. “Labor situation at time of
donation” data could not be analyzed from the EULID sur-
veys because some participants interpreted the question as
asking for a job title or role, whereas other participants inter-
preted the question as asking for time commitment (full time
vs part time). It was not possible to compare these EULID
results with other studies because the EULID tool is rela-
tively new and currently there is only 1 study that reports its
use (presented data set was incomplete)(7).
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Table 1. Donor Demographics.
Donor Organ Gender (M/F) Education at Time of Donation (Degree, Other)a Religiona
Donation
Year
Current Age
(years)
Time Since
Donation (years)
1 Kidney F Associate arts Noneb 1999 70 16
2 Kidney F Master’s Catholic 2003 57 12
3 Kidney F High school Protestant 2005 65 10
4 Kidney F Doctorate Protestant 2006 65 9
5 Kidney M Bachelor’s Catholic 2007 62 8
6 Kidney F Bachelor’s Protestant 2007 61 8
7 Kidney M Bachelor’s Protestant 2007 50 8
8 Kidney M Bachelor’s None 2009 49 6
9 Kidney M Master’s Agnostic 2009 47 6
10 Kidney M Master’s Protestant 2010 66 5
11 Liver M High school None 1999 63 16
12 Liver M Associate arts Protestant 2005 55 10
13 Lung M Bachelor’s Protestant 2000 55 15
Abbreviations: F, female; M, male.
aData collected during prior project. (1)
bBelieves in God but reports no religious affiliation.
Table 3. European Living Donor Satisfaction Survey Data, All Donors.a
Themes Positive Responses, % Neutral Responses, %
Negative
Responses, %
Statistical
Significanceb,c
Feelings about organ donation (Q1, 2) 84.6 15.4 0 < .0001c
Decision-making (Q3, 4, 8, 21, 22) 95.4 4.6 0 < .0001c
Information received (Q5, 7, 9, 10, 11, 26) 82.1 7.7 10.3 < .0001b
Stress from donation (Q6, 16, 18, 19, 20,
27, 35)
57.1 (less than expected
stress)
20.9 (no impact or stress level as
expected)
22.0 (stressed) < .0001b
Protection (Q23, 25, 30, 31, 33) 38.5 41.5 20.0 .0189b
Psychological well-being (Q28, 37, 38,
42, 44)
92.3 1.5 6.2 < .0001c
Social impact (Q24, 29, 32, 39, 49, 50,
51, 52)
43.3 47.1 9.6 < .0001b
Quality of life (Q34, 36, 43, 45, 46, 47, 48) 45.1 44.0 11.0 < .0001b
an ¼ 13.
bw2, 2-tailed, 2 degrees of freedom.
cFisher exact test, 2-tailed.
Table 2. RAND 36-Item Health Survey (Version 1.0) Domain Results.
Domain Mean (SD), n ¼ 13 US Normative SF-36 Data, Mean (SD)a P Value (Unpaired, 2-Tailed t Test)
Physical functioning 92.7 (18.3) 47.6 (10.6) < .0001
Role limits due to physical health 80.8 (38.4) 48.3 (10.9) < .0001
Role limits due to emotional health 100 49.8 (10.7) < .0001
Energy/fatigue/vitality 73.5 (1.1) 51.2 (10.7) < .0001
Emotional well-being 88.9 (8.5) 51.3 (10.2) < .0001
Social functioning 91.5 (22.2) 49.9 (10.7) < .0001
Body pain 82.9 (27.2) 48.4 (10.9) < .0001
General health 80.6 (23.0) 49.1 (10.7) < .0001
Component summary scale
Physical component summary 84.2 (27.4) 47.4 (10.8) < .0001
Mental component summary 88.3 (17.4) 51.7 (10.3) < .0001
Abbreviations: MCS, mental component summary; PCS, physical component summary; SD, standard deviation.
aMales and females aged 55 to 64, n ¼ 1046; http://www.sf-36.org/research/sf98norms.pdf.
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With regard to self-reported health status, there was a
strong, positive correlation between the RAND 36-Item
Health Survey and the EULID (n ¼ 13, Pearson correlation
coefficient: .874). All but 1 donor reported good, very good,
or excellent health status. Five (38.5%) of 13 donors were
aware their graft recipient had died. Three (23.1%) donors
were unaware of the vital status of their graft or the recipient.
The reason for this is these donors never came to know their
recipient after donation. Analysis of the mean MCS scores
comparing donors with deceased recipients (90.8, SD: 10.7)
and alive recipients (82.6, SD: 23.0) finds that both groups
have scores well above US norms. The mean MCS for
donors with alive recipients was lower than the mean MCS
for donors with deceased recipients but not statistically sig-
nificant (P ¼ .4904). Furthermore, this was likely due to 1
donor in the former group enduring severe, chronic disability
as a result of donation.
Discussion
Good Samaritan organ donors are a rare and valuable part of
the donation community, thus understanding their experi-
ence and outcomes is important. Research on the long-
term health and psychosocial outcomes of Good Samaritan
organ donors is rare. Existing studies that report long-term
outcomes of kidney donors do not separately analyze Good
Samaritan donor data from related living donors (6–8). The
resultant pooled data does not allow for exploration of the
experiences of these unique donors. Also, because the
pooled data contain data from Good Samaritan donors, it
cannot be used as control or comparison data.
Overall, this small study of Good Samaritan donor long-
term experiences finds generally positive outcomes for both
physical health and quality of life. Donors overwhelmingly
reported positivity about the donation experience but narra-
tive comments about adverse events and recipient death must
keep transplant teams alert to these critical areas. Specifi-
cally, donor teams should use patient experience data to
inform pre- and postdonor care. Health-care workers should
take an active stance in soliciting patient narratives (pre-op
and post-op) by directly asking donors questions like, What
can I do to improve your stay? (15)What can I do to improve
your care today? (16) Although it can be easy to think of
Good Samaritans as “superhuman” (1) and living donation
as “relatively safe,” long-term outcome data shown in this
study indicate that negative experiences are indeed occurring
in this philanthropic population.
There are many clinical implications. As the experience
set grows, educational information for donor candidates
should be updated so that the informed consent process has
greater accuracy with regard to donation risks (physical,
psychological, and financial). Because some Good Samari-
tan donors eventually discover the identity of their recipients
and even develop relationships with them, recipient loss and
donor grieving should not be left unattended. Donor team
social workers should have psychological and spiritual sup-
port services at the ready for these donors, and access should
not be limited by financial means. Donor surgery techniques
should continue to evolve so as to reduce morbidity and
mortality. Postdonation medical care should be accessible
for all donors, especially in light of their known future risk
of hypertension (17).
Organ donations are a community good, as is giving
pre- and postdonation care to organ donors. Although it
may not be practical to administer “experience surveys”
to all donors pre- and postdonation, all health-care workers
have the daily opportunity to learn their patient’s experi-
ence and potentially improve it, by asking questions
(15,16), listening, showing empathy, and taking action.
Great outcomes and giving great care should not be
assumptions, but rather they require active observation,
questioning, and responding. Good Samaritan organ
donors come to the hospital healthy, give a gift to a stran-
ger, and sometimes leave and linger disabled. Donor teams
should be observing, questioning, and responding in an
effort to maximize their welfare.
Table 4. European Living Donor Satisfaction Survey Narratives.
Positive donation experience
“[The recipient is the] mother of 2 post-donation children and went to med school and is a
practicing doctor. It [donation] was an honor.” (Kidney donor, 8 years postdonation)
“[Donation] is the best thing I have ever done. I would do it again in a heartbeat!” (Liver donor, 16 years postdonation)
“No complications [for donor or recipient]. I consider that a miracle!” (Kidney donor, 8 years postdonation)
“I recovered very quickly with only 2 weeks of real pain (even then, was able to get out although moved very slowly) and no residual
effects.” (Kidney donor, 8 years postdonation)
Negative donation experience
“My spleen was nicked [during nephrectomy] and I had a splenectomy as well as the kidney donation.” (Kidney donor, 9 years postdonation)
“I’ve been turned into an invalid.” (Kidney donor, 5 years postdonation)
“They [hospital] were great before and during the surgery but NO follow-up or concern
later.” (Kidney donor, 12 years postdonation)
“I miss her [recipient] greatly.” (Kidney donor, 6 years postdonation; recipient died 5 years posttransplant)
Neutral or mixed reactions about donation experience
“I am aware that they [recipient] appreciated it a lot but that is all I know.” (Liver donor, 10 years postdonation)
“Unfortunately, he passed away [8 years post-transplant], but [I] still enjoy a close relationship to his father and brother.” (Lung donor, 15
years postdonation)
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The current study has several limitations. The sample size
is small and as such, this study could be considered a pilot
for a future, prospective larger study using the RAND and
EULID tools at short-, medium-, and long-term follow-up.
Also, there is no baseline or medium-term data for the
RAND 36-Item Health Survey or the EULID for this study
population. These surveys were not used in the original study
of this population (1); however, results are consistent. Addi-
tionally, it might not be possible to generalize Good Samar-
itan donation data to the general population of living organ
donors. This is because the motivations of these donors can
be very different and this could potentially impact their per-
ceptions of quality of life, satisfaction with life, donation
decision-making, stress and well-being, and expectations
about donation (1). Also, situational context can impact
questionnaire responses; namely, at the time of study partic-
ipation, one of the donors was recovering from a recent
unrelated surgery which could impact responses pertaining
to health, fatigue, and quality of life, for example. There is
also the possibility that for the donors who did not participate
in this follow-up study (n ¼ 9), some of them might have
declined because of adverse events, thus skewing this sample
set toward positive outcomes. It is suggested that the EULID
survey be further developed to include a formal scoring for-
mula as well as the demographic question about employment
status be clarified.
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